Search Results - "Zaryczański, Janusz"
-
1
Pneumonia hospitalizations of children aged <2 years in Poland before (2013-2016) and after (2017-2018) universal mass vaccination with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine
Published in Human vaccines & immunotherapeutics (30-11-2022)“…As infection with Streptococcus pneumoniae is an important cause of pneumonia in children, the World Health Organization recommends childhood pneumococcal…”
Get full text
Journal Article -
2
D-dimer concentrations in acute urticaria in children
Published in Allergologia et immunopathologia (01-01-2021)“…Urticaria is a clinical entity presenting as wheals, angioedema, or both simultaneously. Elevated D-dimer levels were reported in the course of chronic…”
Get more information
Journal Article -
3
Influenza and Other Prophylactic Vaccination Coverage in Polish Adult Patients Undergoing Allergen Immunotherapy-A Survey Study among Patients and Physicians
Published in Vaccines (Basel) (08-04-2022)“…Vaccines against infectious diseases may raise safety concerns in patients undergoing allergen immunotherapy (AIT). The objective of our study was to…”
Get full text
Journal Article -
4
Pathologic Analysis of Twenty-one Appendices From Children With Multisystem Inflammatory Syndrome Compared to Specimens of Acute Appendicitis: A Cross-sectional Study
Published in The Pediatric infectious disease journal (01-06-2024)“…Multisystem inflammatory syndrome in children (MIS-C) is a rare, severe complication of coronavirus disease 2019, commonly involving the gastrointestinal…”
Get full text
Journal Article -
5
COVID-19 mRNA BNT162b2 vaccine immunogenicity among children with a history of paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS-TS)
Published in Vaccine (16-05-2023)“…•COVID-19 mRNA BNT162b2 vaccine was highly immunogenic for children.•Children with a history of PIMS-TS did respond immunologically to COVID-19…”
Get full text
Journal Article -
6
COVID-19 mRNA BNT162b2 vaccine safety and B-cell and T-cell reactogenicity among children with a history of paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS-TS) - preliminary study
Published in Vaccine (24-03-2023)“…To assess the safety of Pfizer-BioNTech COVID-19 mRNA BNT162b2 vaccine (Comirnaty®) among patients with the anamnesis of paediatric inflammatory syndrome…”
Get full text
Journal Article -
7
Pediatric Inflammatory Multisystem Syndrome (PIMS) Did Occur in Poland during Months with Low COVID-19 Prevalence, Preliminary Results of a Nationwide Register
Published in Journal of clinical medicine (22-10-2020)“…Pediatric inflammatory multisystem syndrome (PIMS) is a new entity in children, likely associated with previous coronavirus disease 19 (COVID-19) infection…”
Get full text
Journal Article -
8
Could Legionella pneumophila infection cause bronchial hyperreactivity
Published in Przegląd epidemiologiczny (2003)“…11 children with bronchial hyperreactivity were tested for Legionella pneumophila serotype 1 and 2-14, including 3 girls, who were treated a year before…”
Get more information
Journal Article -
9
Current practices in diagnosis of Hymenoptera venom allergy in Poland
Published in Postȩpy dermatologii i alergologii (01-04-2021)“…Hymenoptera venom allergy (HVA) is associated with a high risk of anaphylaxis. Effective treatment of HVA patients requires allergologists' familiarity with…”
Get full text
Journal Article